With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

Pulling the Pfizer EUA would remove the only COVID-19 vaccine approved for all children from the US market. The Moderna ...

(Alliance News) - Baillie Gifford US Growth Trust PLC on Tuesday announced that it outperformed the S&P index in its financial year, as it expects the year ahead to present "significant opportunities" ...

Moderna's COVID-19 vaccine, Spikevax, has picked up a full U.S. approval in children aged 6 months to 11 years who are at an increased risk from the disease.

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...

Moderna may offer substantial upside, but it's essential to consider the associated risks. Since hitting their peak in late ...

RSV vaccine recommended for adults 60+ with health issues, infants under 19 months, and all healthy adults 75+. Helps prevent ...